About Innospec (NASDAQ:IOSP)
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and mining markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in an environmental remediation business that manages the cleanup of redundant TEL plants. The company serves oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, formulators of personal care and home care, agrochemical and mining formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554
Debt
Debt-to-Equity Ratio0.26%
Current Ratio2.15%
Quick Ratio1.34%
Price-To-Earnings
Trailing P/E Ratio16.08
Forward P/E Ratio17.12
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.31 billion
Price / Sales1.40
Cash Flow$6.8211 per share
Price / Cash10.79
Book Value$32.91 per share
Price / Book2.24
Profitability
EPS (Most Recent Fiscal Year)$4.66
Net Income$61.80 million
Net Margins4.73%
Return on Equity15.57%
Return on Assets8.71%
Miscellaneous
Employees1,900
Outstanding Shares24,790,000
Innospec (NASDAQ:IOSP) Frequently Asked Questions
What is Innospec's stock symbol?
Innospec trades on the NASDAQ under the ticker symbol "IOSP."
How often does Innospec pay dividends? What is the dividend yield for Innospec?
Innospec declared a semiannual dividend on Wednesday, November 8th. Stockholders of record on Thursday, November 16th will be paid a dividend of $0.39 per share on Monday, November 27th. This represents a dividend yield of 1.12%. The ex-dividend date is Wednesday, November 15th. This is an increase from Innospec's previous semiannual dividend of $0.38. View Innospec's Dividend History.
How were Innospec's earnings last quarter?
Innospec (NASDAQ:IOSP) issued its quarterly earnings data on Tuesday, February, 13th. The specialty chemicals company reported $1.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.13 by $0.34. The specialty chemicals company had revenue of $353.80 million for the quarter. Innospec had a net margin of 4.73% and a return on equity of 15.57%. View Innospec's Earnings History.
When is Innospec's next earnings date?
What price target have analysts set for IOSP?
3 analysts have issued twelve-month price targets for Innospec's stock. Their forecasts range from $65.00 to $65.00. On average, they anticipate Innospec's share price to reach $65.00 in the next twelve months. View Analyst Ratings for Innospec.
Who are some of Innospec's key competitors?
Some companies that are related to Innospec include Olin (OLN), W. R. Grace and (GRA), Ashland (ASH), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), KMG Chemicals (KMG), Nexeo Solutions (NXEO), Innophos (IPHS), OCI Partners (OCIP), Hawkins (HWKN), Liquidmetal Technologies (LQMT) and Gulf Resources (GURE).
Who are Innospec's key executives?
Innospec's management team includes the folowing people:
- Mr. Patrick S. Williams, Pres, CEO & Director (Age 53)
- Mr. Ian P. Cleminson, Exec. VP & CFO (Age 52)
- Dr. P. J. Boon, Chief Operating Officer and Exec. VP (Age 59)
- Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 69)
- Mr. Brian R. Watt, VP of Strategic Planning and Regulatory Affairs (Age 59)
Has Innospec been receiving favorable news coverage?
News headlines about IOSP stock have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innospec earned a coverage optimism score of 0.25 on Accern's scale. They also assigned press coverage about the specialty chemicals company an impact score of 46.31 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Innospec?
Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innospec's stock price today?
One share of IOSP stock can currently be purchased for approximately $73.60.
How big of a company is Innospec?
Innospec has a market capitalization of $1.82 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.
How can I contact Innospec?
Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]
MarketBeat Community Rating for Innospec (IOSP)
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
Innospec (NASDAQ:IOSP) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Innospec in the last 12 months. Their average twelve-month price target is $65.00, suggesting that the stock has a possible downside of 11.68%. The high price target for IOSP is $65.00 and the low price target for IOSP is $65.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Hold | Hold | Buy |
| Consensus Rating Score: | 2.67 | 2.33 | 2.33 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $65.00 | $65.00 | $65.00 | $65.00 |
| Price Target Upside: | 11.68% downside | 3.35% downside | 3.35% downside | 18.72% upside |
Innospec (NASDAQ:IOSP) Consensus Price Target History
Innospec (NASDAQ:IOSP) Analyst Ratings History
Show:
(Data available from 4/26/2016 forward)
Innospec (NASDAQ:IOSP) Dividend Information
Innospec pays an annual dividend of $0.78 per share, with a dividend yield of 1.06%. IOSP's most recent semiannual dividend payment was Monday, November 27. Innospec pays out 16.74% of its earnings out as a dividend.
| Most Recent Dividend: | 11/27/2017 |
| Annual Dividend: | $0.78 |
| Dividend Yield: | 1.06% |
| Payout Ratio: | 16.74% (Trailing 12 Months of Earnings)
18.14% (Based on This Year's Estimates)
16.77% (Based on Next Year's Estimates)
|
Innospec (NASDAQ:IOSP) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 11/8/2017 | semiannual | $0.39 | 1.12% | 11/15/2017 | 11/16/2017 | 11/27/2017 |
| 5/10/2017 | semiannual | $0.38 | 1.2% | 5/18/2017 | 5/22/2017 | 5/31/2017 |
| 11/3/2016 | semiannual | $0.34 | 1.23% | 11/10/2016 | 11/15/2016 | 11/24/2016 |
| 5/4/2016 | semiannual | $0.33 | 1.37% | 5/12/2016 | 5/16/2016 | 5/25/2016 |
| 11/4/2015 | semiannual | $0.31 | 1.08% | 11/12/2015 | 11/16/2015 | 11/25/2015 |
| 5/6/2015 | semiannual | $0.30 | 1.36% | 5/14/2015 | 5/18/2015 | 5/27/2015 |
| 11/5/2014 | semiannual | $0.28 | 1.29% | 11/13/2014 | 11/17/2014 | 11/26/2014 |
| 5/7/2014 | semiannual | $0.27 | 1.27% | 5/15/2014 | 5/19/2014 | 5/28/2014 |
| 11/5/2013 | | $0.50 | | 11/14/2013 | 11/18/2013 | 11/27/2013 |
| 11/6/2013 | semiannual | $0.05 | 0.22% | 11/14/2013 | 11/18/2013 | 11/27/2013 |
(Data available from 1/1/2013 forward)
Innospec (NASDAQ IOSP) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.22%
Institutional Ownership Percentage: 90.80%
Innospec (NASDAQ IOSP) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/15/2018 | Philip John Boon | VP | Sell | 3,558 | $69.69 | $247,957.02 | 31,000 |  |
| 3/7/2018 | Philip Curran | Insider | Sell | 1,268 | $68.24 | $86,528.32 | 2,998 | |
| 2/26/2018 | Catherine Hessner | VP | Sell | 1,382 | $68.24 | $94,307.68 | 27,518 | |
| 2/23/2018 | David Earl Williams | Insider | Sell | 3,142 | $68.54 | $215,352.68 | 16,676 | |
| 2/23/2018 | Ian Cleminson | CFO | Sell | 2,261 | $68.55 | $154,991.55 | 26,685 | |
| 2/21/2018 | Philip John Boon | VP | Sell | 501 | $67.04 | $33,587.04 | 35,439 | |
| 11/30/2017 | Ian Cleminson | CFO | Sell | 5,000 | $71.67 | $358,350.00 | 22,997 | |
| 11/29/2017 | Milton C Blackmore | Director | Sell | 977 | $73.67 | $71,975.59 | 6,977 | |
| 11/28/2017 | Catherine Hessner | VP | Sell | 707 | $71.56 | $50,592.92 | 25,791 | |
| 11/28/2017 | Ian Cleminson | CFO | Sell | 515 | $71.56 | $36,853.40 | 28,878 | |
| 11/28/2017 | Philip Curran | Insider | Sell | 375 | $71.56 | $26,835.00 | 2,968 | |
| 11/24/2017 | Philip Curran | Insider | Sell | 1,352 | $71.05 | $96,059.60 | | |
| 11/22/2017 | Patrick Williams | CEO | Sell | 15,000 | $71.49 | $1,072,350.00 | 174,242 | |
| 11/21/2017 | Brian Watt | VP | Sell | 440 | $70.17 | $30,874.80 | 30,730 | |
| 9/7/2017 | Milton C Blackmore | Director | Buy | 442 | $54.75 | $24,199.50 | 6,000 | |
| 3/17/2017 | Patrick Williams | CEO | Sell | 3,000 | $63.01 | $189,030.00 | 200,265 | |
| 2/17/2017 | Catherine Hessner | VP | Sell | 3,664 | $70.91 | $259,814.24 | 30,705 | |
| 2/17/2017 | Ian Cleminson | CFO | Sell | 5,157 | $70.91 | $365,682.87 | 31,470 | |
| 12/6/2016 | Milton C Blackmore | Director | Sell | 1,089 | $68.35 | $74,433.15 | 6,647 | |
| 11/22/2016 | Ian Malcolm Mcrobbie | VP | Sell | 20,614 | $66.27 | $1,366,089.78 | 42,543 | |
| 11/18/2016 | Hugh Aldous | Director | Sell | 672 | $63.15 | $42,436.80 | 15,060 | |
| 11/16/2016 | Brian Watt | VP | Sell | 3,000 | $61.30 | $183,900.00 | 32,089 | |
| 11/14/2016 | Joachim Roeser | Director | Sell | 8,333 | $60.53 | $504,396.49 | 8,120 | |
| 11/11/2016 | Patrick Williams | CEO | Sell | 17,342 | $60.04 | $1,041,213.68 | 196,926 | |
| 3/16/2016 | Patrick Joseph Mcduff | EVP | Sell | 489 | $43.05 | $21,051.45 | | |
| 3/2/2016 | Catherine Hessner | VP | Sell | 1,455 | $43.80 | $63,729.00 | 30,983 | |
| 2/29/2016 | Patrick Joseph Mcduff | EVP | Sell | 5,540 | $43.56 | $241,322.40 | 1,966 | |
| 2/23/2016 | Ian Cleminson | CFO | Sell | 1,527 | $43.72 | $66,760.44 | 28,116 | |
| 2/23/2016 | Patrick Williams | CEO | Sell | 2,066 | $43.72 | $90,325.52 | 207,217 | |
| 12/4/2015 | Martin Demora Hale | Director | Sell | 10,000 | $57.13 | $571,300.00 | 181,480 | |
| 11/30/2015 | Patrick Williams | CEO | Sell | 12,800 | $58.42 | $747,776.00 | 187,242 | |
| 11/23/2015 | Brian Watt | VP | Sell | 3,000 | $57.47 | $172,410.00 | 34,644 | |
| 11/18/2015 | Ian Malcolm Mcrobbie | VP | Sell | 10,156 | $57.30 | $581,938.80 | 40,889 | |
| 11/18/2015 | Patrick Joseph Mcduff | EVP | Sell | 8,025 | $57.50 | $461,437.50 | | |
| 6/2/2015 | Philip John Boon | VP | Sell | 13,000 | $43.04 | $559,520.00 | | |
| 5/11/2015 | Catherine Hessner | VP | Sell | 5,000 | $44.03 | $220,150.00 | | |
| 3/10/2015 | David Earl Williams | Insider | Sell | 5,060 | $43.14 | $218,288.40 | | |
| 3/4/2015 | Brian Watt | VP | Sell | 3,000 | $44.14 | $132,420.00 | | |
| 3/2/2015 | Patrick Williams | CEO | Sell | 7,338 | $45.12 | $331,090.56 | | |
| 2/24/2015 | Ian Cleminson | CFO | Sell | 5,092 | $43.90 | $223,538.80 | | |
| 2/24/2015 | Ian Malcolm Mcrobbie | VP | Sell | 3,060 | $43.90 | $134,334.00 | | |
| 2/24/2015 | Philip Curran | Insider | Sell | 1,375 | $43.90 | $60,362.50 | | |
| 12/1/2014 | Hugh Aldous | Director | Buy | 1,000 | $42.96 | $42,960.00 | | |
| 8/15/2014 | Hugh Aldous | Director | Buy | 1,590 | $40.41 | $64,251.90 | | |
| 2/25/2014 | Patrick Williams | CEO | Sell | 4,800 | $43.67 | $209,616.00 | | |
| 2/18/2014 | Ian Cleminson | CFO | Sell | 4,819 | $44.26 | $213,288.94 | | |
| 11/20/2013 | Ian Malcolm Mcrobbie | VP | Sell | 15,000 | $45.11 | $676,650.00 | | |
| 8/29/2013 | Philip John Boon | VP | Sell | 1,923 | $41.22 | $79,266.06 | | |
| 5/22/2013 | Mark Bracewell | Insider | Sell | 1,060 | $41.02 | $43,481.20 | | |
| 5/9/2013 | Catherine Hessner | VP | Sell | 5,277 | $40.69 | $214,721.13 | | |
| 5/9/2013 | Mark Bracewell | Insider | Sell | 4,051 | $40.69 | $164,835.19 | | |
| 3/6/2013 | Ian Malcolm Mcrobbie | VP | Sell | 2,886 | $41.69 | $120,317.34 | | |
| 2/15/2013 | Mark Bracewell | Insider | Sell | 1,260 | $41.19 | $51,899.40 | | |
(Data available from 1/1/2013 forward)
Innospec (NASDAQ IOSP) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Brokerages Anticipate Innospec (IOSP) to Announce $0.98 EPS
www.americanbankingnews.com - April 25 at 9:54 AM |
| Innospec (IOSP) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - April 25 at 12:58 AM |
| Innospec (IOSP) Lifted to Buy at Johnson Rice
www.americanbankingnews.com - April 24 at 9:28 AM |
| Innospec (IOSP) Upgraded to Buy by BidaskClub
www.americanbankingnews.com - April 19 at 9:58 AM |
| Innospec (IOSP) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - April 19 at 6:36 AM |
| Zacks Investment Research Downgrades Innospec (IOSP) to Hold
www.americanbankingnews.com - April 18 at 10:16 PM |
| Innospec (IOSP) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 15 at 1:17 PM |
| Innospec (IOSP) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - April 13 at 1:41 AM |
 | Global Oxygen Scavengers Market Opportunities 2018: Clariant International AG., Innospec , Accepta AS, BASF SE, Baker Hughes Incorporated
www.marketwatch.com - April 10 at 9:52 AM |
 | Innospec Schedules First Quarter 2018 Earnings Release and Conference Call
finance.yahoo.com - April 10 at 9:52 AM |
| Innospec (IOSP) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - April 9 at 8:12 AM |
| Analysts Anticipate Innospec (IOSP) Will Post Earnings of $0.98 Per Share
www.americanbankingnews.com - April 8 at 11:19 AM |
| Innospec (IOSP) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 6 at 8:10 PM |
| Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - April 5 at 9:00 AM |
| Innospec (IOSP) Upgraded by ValuEngine to Buy
www.americanbankingnews.com - April 1 at 12:08 AM |
| Monness Crespi & Hardt Lowers Innospec (IOSP) to Neutral
www.americanbankingnews.com - March 31 at 7:42 PM |
| Innospec (IOSP) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - March 29 at 7:58 PM |
| SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Innospec Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - March 26 at 9:54 AM |
 | Form DEFA14A INNOSPEC INC.
www.streetinsider.com - March 23 at 9:27 AM |
| Zacks: Brokerages Anticipate Innospec Inc. (IOSP) to Post $0.98 EPS
www.americanbankingnews.com - March 22 at 11:26 AM |
 | BRIEF-Innospec Says CEO Patrick Williams' FY 2017 Total Compensation Was $7.4 Mln Vs $6.8 Mln
www.reuters.com - March 22 at 9:43 AM |
| Innospec Inc. (IOSP) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 19 at 1:34 AM |
| Innospec Inc. (IOSP) VP Philip John Boon Sells 3,558 Shares
www.americanbankingnews.com - March 16 at 1:19 PM |
| Innospec (IOSP) Raised to Hold at BidaskClub
www.americanbankingnews.com - March 11 at 12:16 AM |
| Innospec Inc. (IOSP) Insider Philip Curran Sells 1,268 Shares
www.americanbankingnews.com - March 9 at 1:03 PM |
| Innospec Inc. (IOSP) Shares Sold by Huber Capital Management LLC
www.americanbankingnews.com - March 6 at 9:50 AM |
| $0.98 EPS Expected for Innospec Inc. (IOSP) This Quarter
www.americanbankingnews.com - March 5 at 9:38 AM |
| Arizona State Retirement System Has $2.86 Million Position in Innospec Inc. (IOSP)
www.americanbankingnews.com - March 5 at 4:40 AM |
| Innospec (IOSP) versus KMG Chemicals (KMG) Critical Comparison
www.americanbankingnews.com - March 4 at 5:10 AM |
| Innospec Inc. (IOSP) Position Lifted by Lazard Asset Management LLC
www.americanbankingnews.com - March 3 at 1:40 PM |
| Innospec Inc. (IOSP) Shares Bought by Schwab Charles Investment Management Inc.
www.americanbankingnews.com - March 2 at 5:54 AM |
| Citadel Advisors LLC Decreases Holdings in Innospec Inc. (IOSP)
www.americanbankingnews.com - February 28 at 10:52 AM |
| Tieton Capital Management LLC Sells 2,730 Shares of Innospec Inc. (IOSP)
www.americanbankingnews.com - February 27 at 2:34 PM |
| Innospec Inc. (IOSP) VP Sells $94,307.68 in Stock
www.americanbankingnews.com - February 27 at 12:28 PM |
| Champlain Investment Partners LLC Lowers Holdings in Innospec Inc. (IOSP)
www.americanbankingnews.com - February 27 at 5:40 AM |
| Innospec Inc. (IOSP) CFO Sells $154,991.55 in Stock
www.americanbankingnews.com - February 26 at 12:16 PM |
| Innospec Inc. (IOSP) Insider David Earl Williams Sells 3,142 Shares
www.americanbankingnews.com - February 26 at 12:16 PM |
| Innospec Inc. (IOSP) Shares Sold by Royce & Associates LP
www.americanbankingnews.com - February 25 at 11:28 AM |
| Innospec (IOSP) Downgraded by Zacks Investment Research to Strong Sell
www.americanbankingnews.com - February 25 at 6:48 AM |
| Wells Fargo & Company MN Has $76.63 Million Position in Innospec Inc. (IOSP)
www.americanbankingnews.com - February 24 at 5:54 AM |
| Innospec Inc. (IOSP) VP Sells $33,587.04 in Stock
www.americanbankingnews.com - February 22 at 12:29 PM |
| Innospec Inc. (IOSP) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 22 at 1:24 AM |
| AdvanSix (ASIX) and Innospec (IOSP) Financial Comparison
www.americanbankingnews.com - February 20 at 7:28 AM |
 | Innospec's (IOSP) CEO Patrick Williams on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - February 17 at 8:59 AM |
| Innospec Inc (IOSP) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 16 at 9:08 AM |
 | Innospec reports 4Q loss
www.cnbc.com - February 14 at 9:10 AM |
| Innospec Inc. to Host Earnings Call
finance.yahoo.com - February 14 at 9:10 AM |
| Innospec (IOSP) Posts Quarterly Earnings Results, Beats Estimates By $0.30 EPS
www.americanbankingnews.com - February 13 at 7:08 PM |
| Critical Analysis: W. R. Grace & Co (GRA) versus Innospec (IOSP)
www.americanbankingnews.com - February 12 at 5:12 PM |
| Market Trends Toward New Normal in Innospec, Southern Copper, Cornerstone OnDemand, Eagle, Northwest Natural Gas, and Ophthotech — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - February 9 at 9:12 AM |
Innospec (NASDAQ:IOSP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Innospec (NASDAQ:IOSP) Income Statement, Balance Sheet and Cash Flow Statement
Innospec (NASDAQ IOSP) Stock Chart for Thursday, April, 26, 2018
Loading chart…
